From: Dual roles for immune metagenes in breast cancer prognosis and therapy prediction
Variable a | Odds ratio | P -value |
---|---|---|
(95% CI) | ||
P L n = 222 (pr = 20, nr = 202) | Â | Â |
 B/P | 1.96 (1.30-2.93) | 0.001 |
 T/NK | 1.70 (1.04-2.77) | 0.03 |
 M/D | 1.64 (1.00-2.71) | 0.51 |
P I n = 230 (pr = 48, nr = 182) | Â | Â |
 B/P | 1.39 (1.06-1.83) | 0.02 |
 T/NK | 2.17 (1.30-3.61) | 0.003 |
 M/D | 1.95 (1.30-2.93) | 0.001 |
P H n = 228 (pr = 82, nr = 146) | Â | Â |
 B/P | 1.50 (1.15-1.96) | 0.003 |
 T/NK | 1.96 (1.24-3.07) | 0.004 |
 M/D | 1.96 (1.37-2.82) | 0.0002 |